Clinical Trial Update: Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update indicates a study evaluating the efficacy and safety of Meropenem combined with Pralurbactam for intra-abdominal infections is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-abdominal Infections

Drugs mentioned

• Meropenem (Meropenem)
• Pralurbactam (Pralurbactam)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Intra-abdominal Infections | Phase 3 | Status: NOT_YET_RECRUITING